{"pmid":32480215,"pmcid":"PMC7255241","title":"Trend of respiratory pathogens during the COVID-19 epidemic.","text":["Trend of respiratory pathogens during the COVID-19 epidemic.","In Italy, the first SARS-CoV-2 infections were diagnosed in Rome, Lazio region, at the end of January 2020, but sustained transmission occurred later, since the end of February. From 1 February to 12 April 2020, 17,164 nasopharyngeal swabs were tested by real time PCR for the presence of SARS-CoV-2 at the Laboratory of Virology of National Institute for Infectious Diseases \"Lazzaro Spallanzani\" (INMI) in Rome. In the same period, coincident with the winter peak of influenza and other respiratory illnesses, 847 samples were analyzed by multiplex PCR assay for the presence of common respiratory pathogens. In our study the time trend of SARS-CoV-2 and that of other respiratory pathogens in the same observation period were analysed. Overall, results obtained suggest that the spread of the pandemic SARS-CoV-2 virus did not substantially affect the time trend of other respiratory infections in our region, highlighting no significant difference in rates of SARS-CoV-2 infection in patients with or without other respiratory pathogens. Therefore, in the present scenario of COVID-19 pandemic, differential diagnosis resulting positive for common respiratory pathogen(s) should not exclude testing of SARS-CoV-2.","J Clin Virol","Sberna, Giuseppe","Amendola, Alessandra","Valli, Maria Beatrice","Carletti, Fabrizio","Capobianchi, Maria Rosaria","Bordi, Licia","Lalle, Eleonora","32480215"],"abstract":["In Italy, the first SARS-CoV-2 infections were diagnosed in Rome, Lazio region, at the end of January 2020, but sustained transmission occurred later, since the end of February. From 1 February to 12 April 2020, 17,164 nasopharyngeal swabs were tested by real time PCR for the presence of SARS-CoV-2 at the Laboratory of Virology of National Institute for Infectious Diseases \"Lazzaro Spallanzani\" (INMI) in Rome. In the same period, coincident with the winter peak of influenza and other respiratory illnesses, 847 samples were analyzed by multiplex PCR assay for the presence of common respiratory pathogens. In our study the time trend of SARS-CoV-2 and that of other respiratory pathogens in the same observation period were analysed. Overall, results obtained suggest that the spread of the pandemic SARS-CoV-2 virus did not substantially affect the time trend of other respiratory infections in our region, highlighting no significant difference in rates of SARS-CoV-2 infection in patients with or without other respiratory pathogens. Therefore, in the present scenario of COVID-19 pandemic, differential diagnosis resulting positive for common respiratory pathogen(s) should not exclude testing of SARS-CoV-2."],"journal":"J Clin Virol","authors":["Sberna, Giuseppe","Amendola, Alessandra","Valli, Maria Beatrice","Carletti, Fabrizio","Capobianchi, Maria Rosaria","Bordi, Licia","Lalle, Eleonora"],"date":"2020-06-02T11:00:00Z","year":2020,"_id":"32480215","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1016/j.jcv.2020.104470","keywords":["respiratory pathogens","sars-cov-2","trend of infection"],"locations":["Italy","Rome","Lazio","INMI","Rome"],"countries":["Italy"],"countries_codes":["ITA|Italy"],"topics":["Diagnosis"],"weight":1,"_version_":1668532089468747776,"score":9.490897,"similar":[{"pmid":32249944,"title":"About the origin of the first two Sars-CoV-2 infections in Italy: inference not supported by appropriate sequence analysis.","text":["About the origin of the first two Sars-CoV-2 infections in Italy: inference not supported by appropriate sequence analysis.","In the 5th February 2020 issue of Journal of Medical Virology a paper was published by Giovannetti et al., entitled \"The first two cases of 2019-nCoV in Italy: where they come from?\"(1) . In this paper a phylogenetic and evolutionary analysis was applied to the virus identified in the first two subjects diagnosed in Italy with 2019-nCoV infection, recently renamed SARS-CoV-2(2) , two Chinese spouses arrived in Italy for tourism. The diagnosis was performed by the virology team under direction of Maria R. Capobianchi, at the National Institute of Infectious Diseases (INMI) in Rome, Italy, where the patients are currently hospitalized. This article is protected by copyright. All rights reserved.","J Med Virol","Carletti, Fabrizio","Lalle, Eleonora","Messina, Francesco","Ippolito, Giuseppe","Capobianchi, Maria R","32249944"],"abstract":["In the 5th February 2020 issue of Journal of Medical Virology a paper was published by Giovannetti et al., entitled \"The first two cases of 2019-nCoV in Italy: where they come from?\"(1) . In this paper a phylogenetic and evolutionary analysis was applied to the virus identified in the first two subjects diagnosed in Italy with 2019-nCoV infection, recently renamed SARS-CoV-2(2) , two Chinese spouses arrived in Italy for tourism. The diagnosis was performed by the virology team under direction of Maria R. Capobianchi, at the National Institute of Infectious Diseases (INMI) in Rome, Italy, where the patients are currently hospitalized. This article is protected by copyright. All rights reserved."],"journal":"J Med Virol","authors":["Carletti, Fabrizio","Lalle, Eleonora","Messina, Francesco","Ippolito, Giuseppe","Capobianchi, Maria R"],"date":"2020-04-07T11:00:00Z","year":2020,"_id":"32249944","source":"PubMed","week":"202015|Apr 06 - Apr 12","doi":"10.1002/jmv.25833","keywords":["coronavirus < virus classification","disease control","statistical inference < biostatistics & bioinformatics"],"locations":["Italy","Italy","Chinese","Italy","Rome","Italy","Italy"],"countries":["Italy","China"],"countries_codes":["ITA|Italy","CHN|China"],"topics":["Mechanism"],"weight":1,"_version_":1666138490959560708,"score":239.0025},{"pmid":32127123,"pmcid":"PMC7055037","title":"Differential diagnosis of illness in patients under investigation for the novel coronavirus (SARS-CoV-2), Italy, February 2020.","text":["Differential diagnosis of illness in patients under investigation for the novel coronavirus (SARS-CoV-2), Italy, February 2020.","A novel coronavirus (SARS-CoV-2) has been identified as the causative pathogen of an ongoing outbreak of respiratory disease, now named COVID-19. Most cases and sustained transmission occurred in China, but travel-associated cases have been reported in other countries, including Europe and Italy. Since the symptoms are similar to other respiratory infections, differential diagnosis in travellers arriving from countries with wide-spread COVID-19 must include other more common infections such as influenza and other respiratory tract diseases.","Euro Surveill","Bordi, Licia","Nicastri, Emanuele","Scorzolini, Laura","Di Caro, Antonino","Capobianchi, Maria Rosaria","Castilletti, Concetta","Lalle, Eleonora","On Behalf Of Inmi Covid-Study Group And Collaborating Centers","32127123"],"abstract":["A novel coronavirus (SARS-CoV-2) has been identified as the causative pathogen of an ongoing outbreak of respiratory disease, now named COVID-19. Most cases and sustained transmission occurred in China, but travel-associated cases have been reported in other countries, including Europe and Italy. Since the symptoms are similar to other respiratory infections, differential diagnosis in travellers arriving from countries with wide-spread COVID-19 must include other more common infections such as influenza and other respiratory tract diseases."],"journal":"Euro Surveill","authors":["Bordi, Licia","Nicastri, Emanuele","Scorzolini, Laura","Di Caro, Antonino","Capobianchi, Maria Rosaria","Castilletti, Concetta","Lalle, Eleonora","On Behalf Of Inmi Covid-Study Group And Collaborating Centers"],"date":"2020-03-05T11:00:00Z","year":2020,"_id":"32127123","source":"PubMed","week":"202010|Mar 02 - Mar 08","doi":"10.2807/1560-7917.ES.2020.25.8.2000170","keywords":["sars-cov-2","differential diagnosis","rapid molecular assay","respiratory pathogens"],"locations":["China","Italy","Italy"],"countries":["Italy","China"],"countries_codes":["ITA|Italy","CHN|China"],"topics":["Diagnosis"],"weight":1,"_version_":1666138492799811584,"score":236.77054},{"pmid":32464333,"title":"First detection of SARS-CoV-2 in untreated wastewaters in Italy.","text":["First detection of SARS-CoV-2 in untreated wastewaters in Italy.","Several studies have demonstrated the advantages of environmental surveillance through the monitoring of sewage for the assessment of viruses circulating in a given community (wastewater-based epidemiology, WBE). During the COVID-19 public health emergency, many reports have described the presence of SARS-CoV-2 RNA in stools from COVID-19 patients, and a few studies reported the occurrence of SARS-CoV-2 in wastewaters worldwide. Italy is among the world's worst-affected countries in the COVID-19 pandemic, but so far there are no studies assessing the presence of SARS-CoV-2 in Italian wastewaters. To this aim, twelve influent sewage samples, collected between February and April 2020 from Wastewater Treatment Plants in Milan and Rome, were tested adapting, for concentration, the standard WHO procedure for Poliovirus surveillance. Molecular analysis was undertaken with three nested protocols, including a newly designed SARS-CoV-2 specific primer set. SARS-CoV-2 RNA detection was accomplished in volumes of 250 ml of wastewaters collected in areas of high (Milan) and low (Rome) epidemic circulation, according to clinical data. Overall, 6 out of 12 samples were positive. One of the positive results was obtained in a Milan wastewater sample collected a few days after the first notified Italian case of autochthonous SARS-CoV-2. The study confirms that WBE has the potential to be applied to SARS-CoV-2 as a sensitive tool to study spatial and temporal trends of virus circulation in the population.","Sci Total Environ","La Rosa, Giuseppina","Iaconelli, Marcello","Mancini, Pamela","Bonanno Ferraro, Giusy","Veneri, Carolina","Bonadonna, Lucia","Lucentini, Luca","Suffredini, Elisabetta","32464333"],"abstract":["Several studies have demonstrated the advantages of environmental surveillance through the monitoring of sewage for the assessment of viruses circulating in a given community (wastewater-based epidemiology, WBE). During the COVID-19 public health emergency, many reports have described the presence of SARS-CoV-2 RNA in stools from COVID-19 patients, and a few studies reported the occurrence of SARS-CoV-2 in wastewaters worldwide. Italy is among the world's worst-affected countries in the COVID-19 pandemic, but so far there are no studies assessing the presence of SARS-CoV-2 in Italian wastewaters. To this aim, twelve influent sewage samples, collected between February and April 2020 from Wastewater Treatment Plants in Milan and Rome, were tested adapting, for concentration, the standard WHO procedure for Poliovirus surveillance. Molecular analysis was undertaken with three nested protocols, including a newly designed SARS-CoV-2 specific primer set. SARS-CoV-2 RNA detection was accomplished in volumes of 250 ml of wastewaters collected in areas of high (Milan) and low (Rome) epidemic circulation, according to clinical data. Overall, 6 out of 12 samples were positive. One of the positive results was obtained in a Milan wastewater sample collected a few days after the first notified Italian case of autochthonous SARS-CoV-2. The study confirms that WBE has the potential to be applied to SARS-CoV-2 as a sensitive tool to study spatial and temporal trends of virus circulation in the population."],"journal":"Sci Total Environ","authors":["La Rosa, Giuseppina","Iaconelli, Marcello","Mancini, Pamela","Bonanno Ferraro, Giusy","Veneri, Carolina","Bonadonna, Lucia","Lucentini, Luca","Suffredini, Elisabetta"],"date":"2020-05-29T11:00:00Z","year":2020,"_id":"32464333","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1016/j.scitotenv.2020.139652","keywords":["covid-19","coronavirus","sars-cov-2","sewage","surveillance","wastewater"],"locations":["Italy","Italian","Milan","Rome","Milan","Rome","Milan","Italian","Italy"],"countries":["Italy"],"countries_codes":["ITA|Italy"],"topics":["Diagnosis"],"weight":1,"_version_":1668079521199292416,"score":233.94962},{"pmid":32408156,"pmcid":"PMC7213959","title":"Co-infection with respiratory pathogens among COVID-2019 cases.","text":["Co-infection with respiratory pathogens among COVID-2019 cases.","Accumulating evidence shows that microbial co-infection increases the risk of disease severity in humans. There have been few studies about SARS-CoV-2 co-infection with other pathogens. In this retrospective study, 257 laboratory-confirmed COVID-19 patients in Jiangsu Province were enrolled from January 22 to February 2, 2020. They were re-confirmed by real-time RT-PCR and tested for 39 respiratory pathogens. In total, 24 respiratory pathogens were found among the patients, and 242 (94.2 %) patients were co-infected with one or more pathogens. Bacterial co-infections were dominant in all COVID-19 patients, Streptococcus pneumoniae was the most common, followed by Klebsiella pneumoniae and Haemophilus influenzae. The highest and lowest rates of co-infections were found in patients aged 15-44 and below 15, respectively. Most co-infections occurred within 1-4 days of onset of COVID-19 disease. In addition, the proportion of viral co-infections, fungal co-infections and bacterial-fungal co-infections were the highest severe COVID-19 cases. These results will provide a helpful reference for diagnosis and clinical treatment of COVID-19 patients.","Virus Res","Zhu, Xiaojuan","Ge, Yiyue","Wu, Tao","Zhao, Kangchen","Chen, Yin","Wu, Bin","Zhu, Fengcai","Zhu, Baoli","Cui, Lunbiao","32408156"],"abstract":["Accumulating evidence shows that microbial co-infection increases the risk of disease severity in humans. There have been few studies about SARS-CoV-2 co-infection with other pathogens. In this retrospective study, 257 laboratory-confirmed COVID-19 patients in Jiangsu Province were enrolled from January 22 to February 2, 2020. They were re-confirmed by real-time RT-PCR and tested for 39 respiratory pathogens. In total, 24 respiratory pathogens were found among the patients, and 242 (94.2 %) patients were co-infected with one or more pathogens. Bacterial co-infections were dominant in all COVID-19 patients, Streptococcus pneumoniae was the most common, followed by Klebsiella pneumoniae and Haemophilus influenzae. The highest and lowest rates of co-infections were found in patients aged 15-44 and below 15, respectively. Most co-infections occurred within 1-4 days of onset of COVID-19 disease. In addition, the proportion of viral co-infections, fungal co-infections and bacterial-fungal co-infections were the highest severe COVID-19 cases. These results will provide a helpful reference for diagnosis and clinical treatment of COVID-19 patients."],"journal":"Virus Res","authors":["Zhu, Xiaojuan","Ge, Yiyue","Wu, Tao","Zhao, Kangchen","Chen, Yin","Wu, Bin","Zhu, Fengcai","Zhu, Baoli","Cui, Lunbiao"],"date":"2020-05-15T11:00:00Z","year":2020,"_id":"32408156","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1016/j.virusres.2020.198005","keywords":["covid-19","co-infection","rt-pcr","sars-cov-2"],"locations":["Jiangsu"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Diagnosis","Treatment"],"weight":1,"_version_":1666950579783467008,"score":226.90103},{"pmid":32475878,"title":"The first pediatric patients with coronavirus disease 2019 (COVID-19) in Japan; The risk of co-infection with other respiratory viruses.","text":["The first pediatric patients with coronavirus disease 2019 (COVID-19) in Japan; The risk of co-infection with other respiratory viruses.","Coronavirus disease 2019 (COVID-19) is a severe infectious disease of the respiratory tract caused by a novel coronavirus, Severe Acute Respiratory Syndrome Coronavirus 2, and has a high mortality rate. The disease emerged from Wuhan, China, in late 2019, and spread to Japan, including Hokkaido, in January 2020. In February 2020, three children were diagnosed with COVID-19 in Furano, Hokkaido, Japan. During this period, influenza and human metapneumovirus infections were prevalent among children in the Furano region. Two of the three cases experienced co-infection with other respiratory viruses, including influenza virus A or human metapneumovirus. To the authors' knowledge, the cases described in the present report were the first pediatric patients with COVID-19 in Japan. In children with COVID-19, the possibility of co-infection with other respiratory pathogens should be considered.","Jpn J Infect Dis","Kakuya, Fujio","Okubo, Hitoshi","Fujiyasu, Hiroaki","Wakabayashi, Iori","Syouji, Masayo","Kinebuchi, Takahiro","32475878"],"abstract":["Coronavirus disease 2019 (COVID-19) is a severe infectious disease of the respiratory tract caused by a novel coronavirus, Severe Acute Respiratory Syndrome Coronavirus 2, and has a high mortality rate. The disease emerged from Wuhan, China, in late 2019, and spread to Japan, including Hokkaido, in January 2020. In February 2020, three children were diagnosed with COVID-19 in Furano, Hokkaido, Japan. During this period, influenza and human metapneumovirus infections were prevalent among children in the Furano region. Two of the three cases experienced co-infection with other respiratory viruses, including influenza virus A or human metapneumovirus. To the authors' knowledge, the cases described in the present report were the first pediatric patients with COVID-19 in Japan. In children with COVID-19, the possibility of co-infection with other respiratory pathogens should be considered."],"journal":"Jpn J Infect Dis","authors":["Kakuya, Fujio","Okubo, Hitoshi","Fujiyasu, Hiroaki","Wakabayashi, Iori","Syouji, Masayo","Kinebuchi, Takahiro"],"date":"2020-06-02T11:00:00Z","year":2020,"_id":"32475878","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.7883/yoken.JJID.2020.181","keywords":["covid-19","sars-cov-2","children","co-infection","respiratory pathogens"],"locations":["Wuhan","China","Japan","Hokkaido","Furano","Hokkaido","Japan","Furano","Japan","Japan"],"countries":["Japan","China"],"countries_codes":["JPN|Japan","CHN|China"],"topics":["Case Report"],"weight":1,"_version_":1668437835071356928,"score":221.5276}]}